IP

Invesco Perpetual

Europe, Oxfordshire, United Kingdom, Henley On Thames

Description

Invesco Perpetual specializes in active investing, passive (ETFs and ETCs), ESG, and factor investing.

Investor Profile

Invesco Perpetual has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series C (25%)
  • Series Unknown (25%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Medical
  • Biopharma
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Invesco Perpetual frequently co-invest with?

Lansdowne Partners
Europe, England, United Kingdom, London
Co-Investments: 2
Woodford Investment Management
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 3
Tanarra Capital
Oceania, Victoria, Australia, Melbourne
Co-Investments: 2
Vertex Pharmaceuticals
North America, Massachusetts, United States, Boston
Co-Investments: 2
Mercia Asset Management
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
Touchstone Innovations
Europe, England, United Kingdom, London
Co-Investments: 1
IP Group
Europe, England, United Kingdom, London
Co-Investments: 2
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 2

What are some of recent deals done by Invesco Perpetual?

Genomics

Oxford, Oxfordshire, United Kingdom

Genomics plc aiming to lead the genomic transformation of healthcare.

BiopharmaBiotechnologyGeneticsHealth CareLife ScienceMedicalTherapeutics
Series BDec 9, 2018
Amount Raised: $9,119,781
Genomics

Oxford, Oxfordshire, United Kingdom

Genomics plc aiming to lead the genomic transformation of healthcare.

BiopharmaBiotechnologyGeneticsHealth CareLife ScienceMedicalTherapeutics
Series BAug 30, 2018
Amount Raised: $32,531,243
Oxford Genetics

Upper Heyford, Somerset, United Kingdom

Oxford Genetics is a biotechnology company producing versatile cloning plasmids for research.

BiotechnologyGenetics
Series UnknownAug 21, 2017
Amount Raised: $9,673,350
Kuur Therapeutics

London, England, United Kingdom

Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.

BiotechnologyHealth CareMedical
Series CMar 15, 2017
Amount Raised: $73,693,868